4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000113
Principal Accounting Officer sold 1,232 shares at $26.26 ($32,352)
- Principal Accounting Officer acquired 4,150 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Washburn Theodore James Jr. · Principal Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,150 | 6,891 | D | ||
| 2023-08-01 | Sale : show line 2 in the form 10b5-1 | −1,232 | $26.26 | $32,352 | 5,659 | D |
| Open-market sales · 1,232 sh · avg $26.26 · $32,352 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-01 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −4,150 | 0 | D |
Loading xslF345X05/wk-form4_1691006558.xml…